Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:2.7.11.11 (
AMPK
)
12,425
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The finding that some K+ channel mRNAs are restricted to certain populations of neurons in the CNS suggests that there are K+ channels tailored to certain neuronal circuits. One such example are the transcripts from the
KV3.2
gene, the majority of which are expressed in thalamic relay neurons. To gain insights into the specific roles of
KV3.2
subunits, site specific antibodies were raised to determine their localization in thalamic relay neurons. Immunohistochemical and focal lesioning studies demonstrate that
KV3.2
proteins are localized to the terminal fields of thalamocortical projections. It is also shown that
KV3.2
channels expressed in vitro are strongly inhibited through phosphorylation by
cAMP-dependent protein kinase
(PKA). Channels containing KV3.1 subunits, which otherwise exhibit nearly identical electrophysiological properties in heterologous expression systems but have a different and less restricted pattern of expression in the CNS, are not affected by PKA. Therefore, this modulation might be associated with the specific roles of
KV3.2
subunits. Furthermore, we demonstrate that
KV3.2
proteins can be phosphorylated in situ by intrinsic PKA.
KV3.2
subunits display properties and have a localization consistent with a role in the regulation of the efficacy of the thalamocortical synapse, and could thereby participate in the neurotransmitter-mediated control of functional states of the thalamocortical system associated with global states of awareness.
...
PMID:Thalamocortical projections have a K+ channel that is phosphorylated and modulated by cAMP-dependent protein kinase. 764 97